○Yuki Toda¹, Ryosuke Yoshimura¹, Masao Itahara¹, Tomoko Uno¹, Susumu Nakata¹, Kanae Yamada¹, Yuri Imai¹, Kazuyuki Takata¹, Eishi Ashihara¹ (1. Kyoto Pharm. Univ.)

○Chiami Moyama¹, Mitsugu Fujita², Shota Ando¹, Keiko Taniguchi¹, Hiromi Ii¹, Susumu Nakata¹ (1. Kyoto Pharm Univ., 2. Faculty of Med., Kindai Univ.)

○Kotaro Matsusaka¹, Yukio Fujiwara², Hitoshi Maeda¹, Hiroshi Watanabe¹, Yoshihiro Komohara², Toru Maruyama¹ (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Grad. Sch. Med. Sci., Kumamoto Univ.)

○Sena Ikemoto¹, Fuminori Sakurai^1,2, Kousuke Takayama², Takahiro Okabe⁶, Shinsaku Togo⁷, Hiroyuki Mizuguchi^1,2,3,4,5 (1. Sch.Pharm.Osaka Univ, 2. Grad.Sch.Pharm.Osaka Univ, 3. Ctr MEI,Osaka Univ, 4. NIBIOHN, 5. OTRI, Osaka Univ, 6. Leading Center for the development and research of cancer medicine, 7. Sch.Med.Juntendo Univ)

○Sato Masaru¹, Momo Jurina¹, Tokida Yuri¹, Iwasaki Hikaru¹, Ohta Tomoyuki¹, Matsumoto Mitsunobu², Tatano Yutaka¹, Yagi Hideki¹ (1. Dept. Pharm. Sci., Sch. Pharm., IUHW, 2. Shionogi Co. Ltd.)

○Satoshi Kofuji¹, Atsuo Sasaki^2,3 (1. Med. Res. Inst., Tokyo Med Den Univ. , 2. Col. Med., Univ. Cincinnati, 3. Inst. Adv. Biosci., Keio Univ.)

○Yuya Terashima¹, Toda Etsuko², Kouji Matsushima¹ (1. Res. Ins. Bio. Sci., Tokyo Univ. Sci., 2. Dep. Ana. Hum. Path., Nippon Med. Sch.)

○Toshiki Aiba¹, Goro Kasuya¹, Makoto Shinoto¹, Toshiyuki Saito¹, Shizuko Kakinuma¹ (1. Quantum Medical Science Directorate,QST)